Restoring men’s fertility after cancer
By Rob Clancy, staff writer. Reviewed by Associate Professor Robin Hobbs
A tragic side-effect of chemotherapy might soon be a thing of the past, with researchers uncovering a vital pathway to restoring men’s fertility after cancer.
The same treatment used to defeat cancer can often have damaging effects on the male reproductive system, leaving many men cancer-free but infertile.
Regeneration pathway discovered
Now researchers at Hudson Institute of Medical Research have for the first time defined the cellular pathways that control regeneration of the male germline – the cells responsible for producing sperm.
Lead researcher, Associate Professor Robin Hobbs, says sperm banking has helped some men to become fathers after chemotherapy, but other men, and those who had cancer treatment as children, never get that opportunity.
“Spermatogonial stem cells (SSCs) in the testes are essential for production of germ cells and sperm in men,” A Prof Hobbs says, “Now, for the first time we have defined the cellular pathways that can allow these cells to regenerate after they have been damaged.”
Treatments to restore fertility of male cancer patients
“While it’s not a cure in itself, our new understanding of these pathways may allow us to develop treatments that restore male fertility after chemotherapy.”
The discovery, published in the journal Nature Communications, is an important step in addressing this major quality of life issue for cancer survivors.
“Understanding the cellular factors that promote the regenerative response of SSCs can ultimately allow us to design treatments to help restore fertility of male cancer patients,” A Prof Hobbs says.
Collaborators | Tin Lap Lee and Jinyue Liao, Chinese University of Hong Kong; Antonella Papa, Monash University; Jason Cain and Vijesh Vaghjiani, Hudson Institute of Medical Research; Fernando Rossello, Melbourne University
This research was supported by | National Health and Medical Research Council (NHMRC)
Journal | Nature Communications
Title | Distinctive molecular features of regenerative stem cells in the damaged male germline
View publication | https://doi.org/10.1038/s41467-022-30130-z
In this article
About Hudson Institute
Hudson Institute’ s research programs deliver in three areas of medical need – inflammation, cancer, women’s and newborn health. More
Hudson News
Get the inside view on discoveries and patient stories
“Thank you Hudson Institute researchers. Your work brings such hope to all women with ovarian cancer knowing that potentially women in the future won't have to go through what we have!”